MWV Episode 72 - Jonathan Eisen - Evolvability, the Built Environment and Open Science

submitted by: MicrobeWorld
Jonathan Eisen is an evolutionary biologist, currently working at University of California, Davis and is the academic editor-in-chief of the open-access journal PLoS Biology. On this episode, Jonathan talks about "evolvability," the probability that organisms can invent new functions. To do this, he has been using genome data in conjunction with experimental information to try and understand the mechanisms by which new functions have originated. Another area of interest for Eisen is the...

Science Nation - Bird Courtship

submitted by: nsf

Fembot helps researchers study America's most bizarre bird. "The sage grouse is the most elaborate and extreme bird we have in the United States," says Gail Patricelli, an animal behaviorist at the University of California (UC), Davis. "We're basically trying to understand why we have animals that are as amazing and beautiful as the peacocks."

A New Electro-Optic Waveguide Architecture and the Unprecedented Devices It Enables

submitted by: icamvid

Scott Davis gives a talk at the LC2CAM conference about a new and potent method to satisfy the long-standing need to actively control light.

Progress and Promise in Huntington's

submitted by: CIRMTV

Huntington's disease (HD) is a genetic neurodegenerative disorder that typically strikes in a person's thirties and leads to death 10-15 years later. Through firsthand stories, this video describes the devastating impact of the disease on families, the inspirational power of patient advocacy, and the promise of stem cell research to find a cure.

Treatment of Epilepsy

submitted by: alex01
Michael Rogawski (University of California, Davis) summarizes his research on the antiepileptic activity of neurosteroids (e.g. ganaxolone, allopregnanolone). They are allosteric modulators of GABAA receptors and are active in many models of epilepsy. They are expected, however, to be most effective in catamenial epilepsy, infantile spasms or adult partial seizures. National Institutes of Health (NIH) is currently sponsoring a clinical trial of progesterone (precursor of allopregnanolone)...